Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial
Year: 2024
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background Recent imaging studies identified a brain network associated with clinical improvement following deep brain stimulation (DBS) in Parkinson's disease (PD), the PD response network. Objectives This study aimed to assess the impact of neuromodulation on PD motor symptoms by targeting this network noninvasively using multifocal transcranial direct current stimulation (tDCS). Methods In a prospective, randomized, double‐blinded, crossover trial, 21 PD patients (mean age 59.7 years, mean Hoehn & Yahr [H&Y] 2.4) received multifocal tDCS targeting the a‐priori network. Twenty‐minute sessions of tDCS and sham were administered on 2 days in randomized order. Movement Disorder Society‐Unified Parkinson's Disease Rating Scale—Part III (MDS‐UPDRS‐III) scores were assessed. Results Before intervention, MDS‐UPDRS‐III scores were comparable in both conditions (stimulation days: 37.38 (standard deviation [SD] = 12.50, confidence interval [CI] = 32.04, 42.73) vs. sham days: 36.95 (SD = 13.94, CI = 30.99, 42.91), P = 0.63). Active stimulation resulted in a reduction by 3.6 points (9.7%) to 33.76 (SD = 11.19, CI = 28.98, 38.55) points, whereas no relevant change was observed after sham stimulation (36.43 [SD = 14.15, CI = 30.38, 42.48], average improvement: 0.5 [1.4%]). Repeated‐measures analysis of variance (ANOVA) confirmed significance (main effect of time: F(1,20)=4.35, P < 0.05). Tukey's post hoc tests indicated MDS‐UPDRS‐III improvement after active stimulation (t [20] = 2.9, P = 0.03) but not after sham (t [20] = 0.42, P > 0.05). In a subset of patients that underwent DBS surgery later, their DBS response correlated with tDCS effects (R = 0.55, P(1) = 0.04). Conclusion Noninvasive, multifocal tDCS targeting a DBS‐derived network significantly improved PD motor symptoms. Despite a small effect size, this study provides proof of principle for the successful noninvasive neuromodulation of an invasively identified network. Future studies should investigate repeated tDCS sessions and their utility for screening before DBS surgery. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Source: Movement Disorders
DOI: 10.1002/mds.29940
Institutions: Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin, Brigham and Women's Hospital, Harvard University, German Center for Neurodegenerative Diseases, Bernstein Center for Computational Neuroscience Berlin, NeuroCure Cluster of Excellence, Massachusetts General Hospital
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,270
Funders: Boston Scientific Corporation, EU Joint Programme – Neurodegenerative Disease Research, Deutsche Forschungsgemeinschaft, Thiemann Stiftung, Berlin Institute of Health, National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke
Awards: Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation, G4510041740, G4750422559, G4965400011, TRR 295: Behandlung motorischer Netzwerkstörungen mittels Neuromodulation, Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease, In Richtung netzwerkbasierter Hirnstimulation, Identifying neuromodulation targets for pain in the human brain, Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy Circuit, Toward Connectomic Deep Brain Stimulation in Obsessive Compulsive Disorder, BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC), Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
OpenAlex ID: W4400983796
